Provexis (PXS) Price & Analysis

Compare

2 Followers

PXS Stock Chart & Stats

0.71 p

0.02 p(3.46%)

At close: Jan 08 4:00 PM EST

0.71 p

0.02 p(3.46%)

Day’s Range― - ―

52-Week Range0.40 p - 1.55 p

Previous CloseN/A

Volume299.72K

Average Volume (3M)426.62K

Market Cap

£26.16M

Enterprise Value25.63M

Total Cash (Recent Filing)£708.09K

Total Debt (Recent Filing)£0.00

Price to Earnings (P/E)―

Beta0.52

Next Earnings

Sep 25, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding2,345,891,400

10 Day Avg. Volume0

30 Day Avg. Volume426,617

Financial Highlights & Ratios

PEG Ratio0.68

Price to Book (P/B)7.92

Price to Sales (P/S)7.95

P/FCF Ratio-30.33

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Debt-free Balance SheetZero reported debt materially reduces refinancing and interest-rate risk, giving management flexibility to prioritize commercial investments or partnerships rather than servicing debt. Over a multi-month horizon this conservatism supports survival while revenue traction builds.

Sharply Accelerating Revenue GrowthA large acceleration in reported revenue indicates growing commercial traction for Fruitflow and partner adoption. If the trend reflects sustainable partner rollouts rather than one-off receipts, it supports scale economies and a pathway to improved margins over the coming months.

Asset-light B2B Ingredient ModelCommercialising a single, science-backed ingredient via B2B agreements is asset-light and scalable: limited capex, potential recurring payments or revenue shares, and broad market reach through partners. Structurally this model can deliver margin expansion as partner volumes rise.

Bears Say

Persistent Negative Cash FlowSustained negative operating and free cash flow creates funding risk: the company may need external financing to sustain operations and commercialisation, which can dilute existing shareholders or constrain strategic investment, limiting long-term execution flexibility.

Very Small Operating ScaleAn ultra-small headcount limits internal capacity to manage sales, regulatory, manufacturing oversight and global partner relations. Reliance on external partners or contractors raises operational concentration risk and can slow the company’s ability to convert demand into sustained, wider-scale revenue.

Structurally Weak Margins And Ongoing LossesDeep negative margins signal the business has yet to achieve unit economics at scale. Even with rising revenue, persistent operating losses limit reinvestment capacity and make long-term viability contingent on either substantial margin improvement or continued external funding.

Provexis News

Provexis Hit by Interim Sales Dip as Supply Delay Masks Expanding Fruitflow Pipeline

The latest update is out from Provexis ( ($GB:PXS) ). Provexis reported unaudited interim revenue of £364,000 for...

3M ago

Provexis Secures Shareholder Support and Advances in Chinese Market

Provexis ( ($GB:PXS) ) has shared an update. Provexis plc announced that all resolutions were passed at its...

4M ago

Provexis Reports Strong Revenue Growth and Expands Global Reach

Provexis ( ($GB:PXS) ) has issued an announcement. Provexis plc reported a 61% increase in revenue for the...

5M ago

Provexis Reports Strong Revenue Growth and Strategic Expansion

The latest update is out from Provexis ( ($GB:PXS) ). Provexis plc reported a 61% increase in revenue...

5M ago

Provexis Faces Temporary Trading Suspension Amid Financial Reporting Delay

Provexis ( ($GB:PXS) ) has issued an update. Provexis plc announced a delay in the publication of its...

6M ago

Provexis Grants Options and Warrants to CEO and Consultants

Provexis ( ($GB:PXS) ) has issued an update. Provexis plc announced the grant of 56,000,000 options and 58,730,000...

1y ago

Provexis Announces Total Voting Rights and Advances in Chinese Market

Provexis ( ($GB:PXS) ) has provided an announcement. Provexis has announced its total voting rights as 2,345,891,239 ordinary...

1y ago

Provexis PLC Reports Robust Revenue Growth and Strategic Partnerships

Provexis ( ($GB:PXS) ) has shared an update. Provexis PLC reports a 103% increase in revenue for the...

1y ago

Provexis Strengthens Supply Chain with New Fruitflow Inventory Purchase

Provexis ( ($GB:PXS) ) just unveiled an update. Provexis announced the purchase of additional Fruitflow® II SD inventory...

1y ago

Provexis Gains Shareholder Support and Expands Market Reach

Provexis (GB:PXS) has released an update. Provexis PLC announced the successful passage of all resolutions at its recent...

1y ago

PXS FAQ

What was Provexis PLC’s price range in the past 12 months?

Provexis PLC lowest share price was 0.40 p and its highest was 1.55 p in the past 12 months.

What is Provexis PLC’s market cap?

Provexis PLC’s market cap is £26.16M.

When is Provexis PLC’s upcoming earnings report date?

Provexis PLC’s upcoming earnings report date is Sep 25, 2026 which is in 193 days.

How were Provexis PLC’s earnings last quarter?

Currently, no data Available

Is Provexis PLC overvalued?

According to Wall Street analysts Provexis PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Provexis PLC pay dividends?

Provexis PLC does not currently pay dividends.

What is Provexis PLC’s EPS estimate?

Provexis PLC’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Provexis PLC have?

Provexis PLC has 2,345,891,400 shares outstanding.

What happened to Provexis PLC’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Provexis PLC?

Currently, no hedge funds are holding shares in GB:PXS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Provexis PLC

Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.